Search - tctmd.com

Presenter: Jin Joo Park, Kyung Woo Park, Jeehoon Kang, Ki-Hyun Jeon, Si-Hyuck Kang, Jung-Kyu Han, Sang Eun Lee, Han-Mo Yang, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim

January 31, 2013

Presentation TCT 2013

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Presenter: Atsushi Hirohata, Eiki Hirose, Yuhei Kobayashi, Minako Ohara, Tohru Ohe, Fumihiko Sano, Hiroya Takafuji, Hiroyuki Takinami, Keizo Yamamoto, Ryo Yoshioka

January 31, 2013

Presentation TCT 2013

Meta-analysis Comparing Bleeding Rates After Low Versus High Dose Clopidogrel In Patients Undergoing Percutaneous Coronary Intervention And Receiving A Glycoprotein IIb/IIIa...

Presenter: Christopher Huff, Shikhar Agarwal, James Lai, Clay Cauthen, A. Michael Lincoff, Leslie Cho

January 31, 2013

Advertisement

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

La PCI Radial + Bivalirudina es Eficaz Minimizando el Riesgo Hemorrágico

JAMA Review Tackles Intricacies of Medical Therapy After PCI

HORIZONS-AMI: La Bivalirudina y Taxus Mejoran los Resultados en Pacientes sometidos a una PCI en la Arteria Descendente Anterior Izda

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Danish Registry Suggests Aspirin Unnecessary in A-fib Patients After MI or PCI

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

STREAM: Fibrinolysis Strategy Effective for STEMI Patients Far From PCI Hospital

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Un Subestudio del AIDA STEMI No Confirma Ventaja alguna para el Abciximab Intracoronario

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Atorvastatin Boosts Clopidogrel Efficacy in Patients with High Platelet Reactivity

La Atorvastatina Potencia la Eficacia del Clopidogrel en Pacintes con Alta Reactividad Plaquetaria

Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials.

Paraoxonase 1 Gene Polymorphism Does Not Affect Clopidogrel Response Variability But Is Associated with Clinical Outcome After Percutaneous Coronary Intervention

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Meta-analysis Comparing Bleeding Rates After Low Versus High Dose Clopidogrel In Patients Undergoing Percutaneous Coronary Intervention And Receiving A Glycoprotein IIb/IIIa...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content